Impinj Inc vs 22nd Century Group Inc — how do they compare? Impinj Inc trades at $189.55 (market cap $5.60B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Impinj Inc is far larger — about 9008× 22nd Century Group Inc's market cap, and Impinj Inc is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Impinj Inc for 22 Days and 22nd Century Group Inc for 32 Days on average.
| PI | XXII | |
|---|---|---|
Market Cap | $5.60B | $621.67K |
Volume | 9,929 | 45,625 |
Sector | Technology | Consumer Staples |
52-Week High | $241.91 | $483.00 |
52-Week Low | $91.34 | $0.80 |
Typical Hold Time | 22 Days | 32 Days |
Enterprise Value | $5.73B | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
Impinj (PI) trades at $183.37, down 4.01% today, with strong analyst support (16 Buy, 6 Hold ratings) despite negative profitability metrics. The stock shows bullish technical signals with recent earnings beats in Q1 and Q2 2026, though Q4 2025 missed expectations. Recent news highlights the company's focus on RFID technology growth and upcoming Q3 2026 results announcement.
While technical indicators suggest near-term strength, fundamental challenges persist with negative net income margin (-7.26%) and elevated valuations (P/S 14.83). The consensus price target of $178.83 implies slight downside risk, requiring careful monitoring of Q3 earnings and profitability improvements for sustained investor confidence.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →